Polyclonal Antibody to Human NGAL

Description

Polyclonal Antibody to Human NGAL
Catalog number: B2012209
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 100 ug
Molecular Weight or Concentration: 1 mg/mL
Supplied as: Solution
Applications: molecular tool for various biochemical applications
Storage: -20°C
Keywords: neutrophil gelatinase-associated lipocalin, Lipocalin-2, LCN2
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1: Shang W, Wang Z. The Update of NGAL in Acute Kidney Injury Curr Protein Pept Sci. 2017;18(12):1211-1217.
2: Buonafine M, Martinez-Martinez E, Jaisser F. More than a simple biomarker: the role of NGAL in cardiovascular and renal diseases Clin Sci (Lond). 2018 May 8;132(9):909-923.
3: Bauvois B, Susin SA. Revisiting Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Cancer: Saint or Sinner? Cancers (Basel). 2018 Sep 18;10(9):336.
4: Roli L, Pecoraro V, Trenti T. Can NGAL be employed as prognostic and diagnostic biomarker in human cancers? A systematic review of current evidence Int J Biol Markers. 2017 Mar 2;32(1):e53-e61.
5: Gagneux-Brunon A, Delanaye P, Legrand D, Cavalier E, Mariat C. [NGAL, biomarker of acute kidney injury in 2012] Nephrol Ther. 2012 Dec;8(7):508-15.
6: Soni SS, Cruz D, Bobek I, Chionh CY, Nalesso F, Lentini P, de Cal M, Corradi V, Virzi G, Ronco C. NGAL: a biomarker of acute kidney injury and other systemic conditions Int Urol Nephrol. 2010 Mar;42(1):141-50.
7: Marakala V. Neutrophil gelatinase-associated lipocalin (NGAL) in kidney injury – A systematic review Clin Chim Acta. 2022 Nov 1;536:135-141.
8: Guo Y, Zhai J, Zhang J, Zhou H. NGAL protects in nasopharyngeal carcinoma by inducing apoptosis and blocking epithelial-mesenchymal transition Oncol Lett. 2020 Jun;19(6):3711-3718.
9: Candido S, Abrams SL, Steelman LS, Lertpiriyapong K, Fitzgerald TL, Martelli AM, Cocco L, Montalto G, Cervello M, Polesel J, Libra M, McCubrey JA. Roles of NGAL and MMP-9 in the tumor microenvironment and sensitivity to targeted therapy Biochim Biophys Acta. 2016 Mar;1863(3):438-448.
10: Smertka M, Chudek J. Using NGAL as an early diagnostic test of acute kidney injury Ren Fail. 2012;34(1):130-3.

Products Related to Polyclonal Antibody to Human NGAL can be found at Proteins